Business Segments Thermo Fisher Scientific Inc.
Equities
TMO
US8835561023
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
529.36 USD | +1.63% | -0.05% | -0.27% |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Measuring, Analyzing, and Controlling Instruments | ||||||||||
Laboratory Products and Biopharma Services | 10.6B | 12.24B | 14.86B | 22.51B | 23.04B | |||||
Total Assets | 21.76B | 22.71B | 52.64B | 51.28B | 51.09B | |||||
CAPEX | -554M | -772M | -1.33B | -1.4B | -1.01B | |||||
D&A | 292M | 342M | 423M | 614M | 669M | |||||
Operating Income | 1.32B | 1.27B | 1.84B | 2.87B | 3.36B | |||||
Analytical Instruments | 5.52B | 5.12B | 6.07B | 6.62B | 7.26B | |||||
Total Assets | 9.9B | 9.77B | 9.69B | 10.02B | 10.25B | |||||
CAPEX | -64M | -74M | -79M | -140M | -87M | |||||
D&A | 75M | 76M | 83M | 83M | 93M | |||||
Operating Income | 1.27B | 808M | 1.2B | 1.51B | 1.91B | |||||
Life Sciences Tools and Services | ||||||||||
Life Sciences Solutions | 6.86B | 12.17B | 15.63B | 13.53B | 9.98B | |||||
Total Assets | 18.31B | 20.21B | 22.75B | 21.85B | 20.19B | |||||
CAPEX | -151M | -392M | -810M | -490M | -178M | |||||
D&A | 130M | 140M | 197M | 214M | 220M | |||||
Operating Income | 2.45B | 6.11B | 7.82B | 5.58B | 3.42B | |||||
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
Specialty Diagnostics | 3.72B | 5.34B | 5.66B | 4.76B | 4.4B | |||||
Total Assets | 5.87B | 6.53B | 6.01B | 5.54B | 8.64B | |||||
CAPEX | -83M | -175M | -167M | -112M | -121M | |||||
D&A | 67M | 100M | 128M | 75M | 86M | |||||
Operating Income | 930M | 1.37B | 1.28B | 1.02B | 1.12B | |||||
Corporate/Other | - | - | - | - | - | |||||
Total Assets | 2.55B | 9.82B | 4.03B | 8.46B | 8.56B | |||||
CAPEX | -74M | -61M | -140M | -98M | -80M | |||||
Operating Income | - | - | - | - | - | |||||
Eliminations | -1.15B | -2.66B | -3.01B | -2.52B | -1.83B |
Geographical Revenue Distribution History
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
United States | 12.37B | 16.44B | 18.91B | 23.82B | 22.01B | |||||
Total Assets | 3.1B | 3.69B | 5.58B | 6.31B | 6.35B | |||||
Others | 10.42B | 12.99B | 16.86B | 17.3B | 20.84B | |||||
Total Assets | 2.35B | 3B | 4.29B | 4.56B | 4.65B | |||||
Japan | - | - | - | - | - | |||||
China | 2.75B | 2.8B | 3.44B | 3.79B | - | |||||
United Kingdom | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Germany | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - |
- Stock Market
- Equities
- TMO Stock
- Financials Thermo Fisher Scientific Inc.
- Business Segments